Helicobacter pylori resistance in Australia: a call for active surveillance

Intern Med J. 2024 Feb;54(2):354-355. doi: 10.1111/imj.16331.

Authors

Ravin Hettiarachchi^{1

2}, Raed Simhairi¹, Juliette Holland¹

Affiliations

¹ Department of Microbiology, Laverty Pathology, Sydney, New South Wales, Australia.
² St George and Sutherland Clinical School, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.

PMID: 38350657
DOI: 10.1111/imj.16331

No abstract available

Publication types

Letter

MeSH terms

Anti-Bacterial Agents / pharmacology
Anti-Bacterial Agents / therapeutic use
Australia / epidemiology
Clarithromycin
Drug Resistance, Bacterial
Helicobacter Infections* / drug therapy
Helicobacter Infections* / epidemiology
Helicobacter pylori*
Humans
Metronidazole
Microbial Sensitivity Tests
Watchful Waiting

Substances

Anti-Bacterial Agents
Clarithromycin
Metronidazole